aod9604 cjc troche Chevy Chase AOD 9604 Anti-Obesity Peptide for Fat Loss CJC-1295 / Ipamorelin Peptide Injections

Boosts Natural Energy Fights fatigue by supporting red blood cell production and healthy metabolism, without the crash of stimulants

Zenobi PD, Guler HP, Zapf J, Froesch ER

Physical symptoms may include weakness, pale or yellowish skin, numbness or tingling in extremities, balance difficulties, mood changes including depression or irritability, and tongue inflammation

Off-period (weeks 12+) : 4 to 6 weeks off lets baseline NNMT activity reset before the next cycle

There is no FDA-approved indication for any patient population

Sports and WADA compliance: AOD-9604 is explicitly included on the World Anti-Doping Agency (WADA) Prohibited List, making it banned in all competitive sports regardless of dosage or route of administration Thevis, Mario, and Wilhelm Schnzer